OTCMKTS:CLSH CLS Holdings USA (CLSH) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free CLSH Stock Alerts $0.06 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.04▼$0.0652-Week Range$0.03▼$0.12Volume2,000 shsAverage Volume120,404 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest Get CLS Holdings USA alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About CLS Holdings USA Stock (OTCMKTS:CLSH)CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. It offers its products under Oasis Cannabis and City Trees brand names. The company's concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.Read More CLSH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLSH Stock News HeadlinesApril 9, 2024 | benzinga.comEclipsing Prohibition: US Cannabis Industry Report Shows Growth Amid Regulatory AnticipationMarch 5, 2024 | finanznachrichten.deCLS Holdings USA, Inc.: CLS Holdings Partners with SOMA to Launch Innovative Solventless Cannabis VapeApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 11, 2024 | finance.yahoo.comCLS Holdings USA, Inc. (CLSH)February 8, 2024 | msn.comCLS Holdings Celebrates City Trees’ Record Sales January 2024February 6, 2024 | finanznachrichten.deCLS Holdings USA, Inc.: City Trees Production Facility Achieves Unprecedented Milestone with Record-Breaking Sales MonthFebruary 6, 2024 | finance.yahoo.comCity Trees Production Facility Achieves Unprecedented Milestone with Record-Breaking Sales MonthFebruary 4, 2024 | morningstar.comCLS Holdings USA Inc CLSHApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 18, 2024 | msn.comCLS Holdings USA repays $3.88M in principal debenture obligationsJanuary 16, 2024 | finance.yahoo.comCLS Holdings USA Inc. (“CLSH”) Announces Repayment of $3,875,094 in Principal Debenture ObligationsDecember 14, 2023 | finance.yahoo.comOasis Cannabis Dispensaries' 8-Year Anniversary: A Celebration of Success, Growth, and Employee DedicationNovember 15, 2023 | finance.yahoo.comCity Trees Announces New Market Venture in New Mexico Through Licensing Agreement.October 15, 2023 | seekingalpha.comCLS Holdings USA reports Q1 resultsOctober 12, 2023 | finanznachrichten.deCLS Holdings USA, Inc.: CLS Reports Fiscal First Quarter 2024 Financial ResultsOctober 12, 2023 | finance.yahoo.comCLS Reports Fiscal First Quarter 2024 Financial ResultsAugust 25, 2023 | finance.yahoo.comCLS Holdings USA, Inc. 2023 CEO Address to ShareholdersAugust 24, 2023 | finanznachrichten.deCLS Holdings USA, Inc.: CLS Holdings Reports Fiscal Year End 2023 Financial Results and Operational HighlightsAugust 24, 2023 | finance.yahoo.comCLS Holdings Reports Fiscal Year End 2023 Financial Results and Operational HighlightsAugust 18, 2023 | finanznachrichten.deCLS Holdings USA, Inc.: Oasis Cannabis Dispensary Launches Their New and Improved App to Enhance the Customer ExperienceAugust 16, 2023 | finance.yahoo.comOasis Cannabis Dispensary Launches Their New and Improved App to Enhance the Customer ExperienceAugust 8, 2023 | finance.yahoo.comOasis Cannabis Utilizing AI-Powered Budtender Offering Personalized Recommendations & ChatGPT AgentAugust 8, 2023 | finanznachrichten.deCLS Holdings USA, Inc.: Oasis Cannabis Utilizing AI-Powered Budtender Offering Personalized Recommendations & ChatGPT AgentAugust 2, 2023 | finance.yahoo.comOasis Employee Appreciation Month for August 2023July 27, 2023 | finance.yahoo.comCLS Holdings USA, Inc. Discusses Growth Strategy and Significant Debt Reduction with The Stock Day PodcastJuly 19, 2023 | benzinga.comOasis Cannabis Launches VIP Loyalty ProgramJuly 19, 2023 | finanznachrichten.deCLS Holdings USA, Inc.: Oasis Cannabis Successfully Launches VIP Loyalty Program, Driving Improved Cash Flow and Customer SatisfactionSee More Headlines Receive CLSH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CLS Holdings USA and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:CLSH CUSIPN/A CIK1522222 Webwww.clsholdingsinc.com Phone(416) 992-4539FaxN/AEmployees86Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Andrew J. Glashow (Age 61)CEO, President, Principal Financial & Accounting Officer, Secretary and Chairman Comp: $300.72kDr. Dominick Monaco (Age 44)Chief Science Officer Comp: $177.42kMs. Charlene Soco (Age 33)Executive Vice President of Finance Comp: $175.69kMs. Jamie Dickson (Age 46)Chief Administrative Officer & Secretary Key Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors CLSH Stock Analysis - Frequently Asked Questions How have CLSH shares performed in 2024? CLS Holdings USA's stock was trading at $0.0425 on January 1st, 2024. Since then, CLSH stock has increased by 29.4% and is now trading at $0.0550. View the best growth stocks for 2024 here. Are investors shorting CLS Holdings USA? CLS Holdings USA saw a increase in short interest in March. As of March 31st, there was short interest totaling 42,700 shares, an increase of 119.0% from the March 15th total of 19,500 shares. Based on an average daily volume of 107,000 shares, the short-interest ratio is presently 0.4 days. View CLS Holdings USA's Short Interest. What other stocks do shareholders of CLS Holdings USA own? Based on aggregate information from My MarketBeat watchlists, some companies that other CLS Holdings USA investors own include Fulcrum Therapeutics (FULC), iAnthus Capital (ITHUF), KushCo (KSHB), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Charlotte's Web (CWBHF), Kaleido Biosciences (KLDO) and Planet 13 (PLNHF). How do I buy shares of CLS Holdings USA? Shares of CLSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CLSH) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CLS Holdings USA, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.